Mercury Systems Inc (MRCY) Jumps 7.98% on January 27

Equities Staff |

Mercury Systems Inc (MRCY) was among the biggest gainers on the Russell 2000 for Wednesday January 27 as the stock popped 7.98% to $18.95, representing a gain of $1.4 per share. Some 661,205 shares traded hands on 4,061 trades, compared with an average daily volume of 155,266 shares out of a total float of 34.75 million. The stock opened at $18.48 and traded with an intraday range of $19.20 to $17.63.

After today's gains, Mercury Systems Inc reached a market cap of $658.54 million. Mercury Systems Inc has had a trading range between $19.99 and $13.37 over the last year, and it had a 50-day SMA of $18.52 and a 200-day SMA of $16.05.

The stock has a P/E Ratio of 48.8.

Mercury Systems Inc is engaged in providing specialized processing subsystems and services for critical commercial, defense and intelligence applications.

Mercury Systems Inc is based out of Chelmsford, MA and has some 635 employees. Its CEO is Mark Aslett.

For a complete fundamental analysis analysis of Mercury Systems Inc, check out’s Stock Valuation Analysis report for MRCY. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets


Pinterest is a visual discovery and planning tool. Users ("Pinners") use the site and apps to get ideas for their future, such as recipes, places to travel, and products to…


Snapchat is the fastest way to share a moment with friends. The mobile app, allows users to not only share photos with friends but also control how long they can…